Andere talen Co-Diagnostics, Inc.

Aandelen

CODX

US1897631057

Beurs gesloten - Nasdaq Andere beurzen 22:30:00 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,21 ^USD	+0,83%		+9,01%	-9,02%

12/04	Co-Diagnostics, Inc. Huldigt nieuwe productiefaciliteit in Utah in met lintjesknipper	CI
04/04	Co-Diagnostics, Inc. Benoemt Uitvoerende Benoemingen	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast	25/04
Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan	24/04
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event	15/04
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event	12/04
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event	12/04
Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions	04/04
Co-Diagnostics, Inc. Appoints Executive Appointments	04/04
Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address	21/03
Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England	18/03
Co-Diagnostics, Inc. Appoints Richard Abbott as President	15/03
Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.	14/03
Co-Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results	14/03
Co-Diagnostics Gets Approval From India's Central Drugs Standard Control Organization For Manufacturing, Sale of Influenza Multiplex Test	07/03
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test	07/03
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast	29/02
Southern District Of New York Declines To Dismiss Claims In Putative Class Action Against Medical Test Manufacturer	20/02
Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024	01/02
Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12	03/01
Co-Diagnostics Submits PCR COVID-19 Test and PCR Pro Instrument for FDA Review	27/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Co-Diagnostics, Inc.

Aandelen

CODX

US1897631057

Andere talen

Filters